GP-3269

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameGP-3269
Drug Alias NameGP-3269GP-1-3269
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdenosine kinase inhibitors
TargetsAdenosine kinase
Therapy Area/IndicationsPainEpilepsyParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson
Active IndicationsN/A
Inactive IndicationsPainEpilepsyParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A